MHC I	Major histocompatibility complex class I
PD-L1	Programmed cell death ligand 1
CTLA-4	Cytotoxic T-lymphocyte associated protein 4
NK	Natural killer
HLA	Human leukocyte antigen
LOH	Loss of heterozygosity
NSCLCs	Non-small-cell lung cancers
TCGA	The Cancer Genome Atlas
TRACERx	TRAcking Cancer Evolution through Therapy (Rx)
TCR	T cell antigen receptor
ICIs	Immune checkpoint inhibitors
Ig	Immunoglobulin
OS	Overall survival
PFS	Progression-free survival
TMB	Tumor mutation burden
APCs	Antigen-presenting cells
CD47-SIRPα	CD47-signal-regulatory protein α
DCs	Dendritic cells
FLT3L	FMS-like tyrosine kinase 3 ligand
TGFβ	Transforming growth factor- β
CCL	CC-chemokine ligand
VEGF	Vascular endothelial growth factor
NY-ESO-1	New York esophageal squamous cell carcinoma 1
TILs	Tumor-infiltrating lymphocytes
CAR	Chimeric antigen receptor